MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers personal lines of property and casualty insurance, including private passenger automobile, homeowners', and personal excess liability insurance. Further, it provides fixed and variable annuities, and pension products; accident and health products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
IPO Year: 2000
Exchange: NYSE
Website: metlife.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $97.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $97.00 | Buy | TD Cowen |
| 9/5/2024 | $91.00 | Overweight | Barclays |
| 1/8/2024 | $80.00 | Neutral → Buy | Goldman |
| 11/17/2023 | $71.00 | Overweight | Barclays |
| 10/5/2023 | $71.00 | Hold | Deutsche Bank |
| 9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
| 1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
| 12/9/2022 | $86.00 → $82.00 | Buy → Hold | Jefferies |
| 9/22/2022 | Mkt Perform | Raymond James |
BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00
TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
Goldman upgraded MetLife from Neutral to Buy and set a new price target of $80.00
Barclays resumed coverage of MetLife with a rating of Overweight and set a new price target of $71.00
Deutsche Bank initiated coverage of MetLife with a rating of Hold and set a new price target of $71.00
Jefferies upgraded MetLife from Hold to Buy and set a new price target of $72.00 from $58.00 previously
Goldman downgraded MetLife from Buy to Neutral and set a new price target of $78.00 from $80.00 previously
Jefferies downgraded MetLife from Buy to Hold and set a new price target of $82.00 from $86.00 previously
Raymond James initiated coverage of MetLife with a rating of Mkt Perform
AM Best has assigned a Long-Term Issue Credit Rating of "bbb+" (Good) to the newly issued $1 billion, 6.35% subordinated notes, due March 15, 2055, issued by MetLife, Inc. (MetLife) (headquartered in New York, NY) (NYSE:MET). The outlook assigned to this Credit Rating (rating) is stable. All other ratings of MetLife and its subsidiaries remain unchanged. MetLife's proforma adjusted financial leverage and the historical interest coverage are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, inc
MetLife Xcelerator evolves and transforms into a business unit to transform embedded insurance in the region. Driving insurance inclusion through disruptive technology, strategic partnerships, and a fully digital access model as part of MetLife's New Frontier strategy. MetLife, a global leader in insurance solutions, announces the creation of a new regional business unit in Latin America by the name of MetLife Xcelerator, marking a significant milestone in the evolution of the MetLife Xcelerator platform and execution of the company's New Frontier strategy. Designed to lead the transformation of embedded insurance and democratize access to financial protection, the MetLife Xcelerator p
As economic stress takes its toll, MetLife's 23rd annual Employee Benefit Trends Study finds employees are placing greater trust in employers to provide stability and support MetLife's 2025 U.S. Employee Benefit Trends Study reveals notable drops in holistic health (-5%), productivity (-5%) and engagement (-7%) across the workforce and finds the majority of employees cite financial concerns, including rising medical costs (77%) and economic uncertainty (68%), as their primary source of stress. Click here to download MetLife's 2025 Employee Benefit Trends Study (EBTS) Amid social and economic turmoil, employees are turning to their employers for stability and support, while trust outside
AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "aa-" (Superior) of the members of Metropolitan Life Insurance Group (collectively referred to as MetLife or the group). Concurrently, AM Best has affirmed the Long-Term ICR of "a-" (Excellent) and the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of MetLife, Inc. (headquartered in New York, NY) (NYSE:MET). The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of companies and Long- and Short-Term IRs.) The ratings reflect MetLife's balance sheet strength, which AM Best assesses as strong, as w
MetLife, Inc. (NYSE:MET) today announced that it has confirmed its previously announced declaration of the first quarter 2025 dividend of $0.35516415 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will set an ex-dividend date for the Series A preferred stock. The dividend will be payable March 17, 2025, to shareholders of record as of Feb. 28, 2025, due to the record date occurring on Sunday, March 2, 2025. About MetLife MetLife,
MetLife, Inc. (NYSE:MET) today announced that Christian Mumenthaler has been elected to its board of directors, effective May 1, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225499879/en/Christian Mumenthaler named to MetLife's board of directors (Photo: Business Wire) Mumenthaler led Swiss Re as Group Chief Executive Officer for eight years until June 2024 and was a member of the Group Executive Committee for more than a decade. During his more than 25-year career at the Zurich-based global reinsurer, Mumenthaler held numerous senior leadership roles including Group Chief Risk Officer and Head of Life & Health. He
Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, will participate in a fireside chat at the Raymond James 46th Annual Institutional Investors Conference on Wednesday, March 5, 2025, beginning at 9:15 a.m. (ET). A live webcast of the presentation will be available over the internet at https://wsw.com/webcast/rj131/met/1467270. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation will be available until Wednesday, March 12, 2025, at 11:59 p.m. (ET) at the same website beginning one ho
MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2024 results. Full Year Results Summary Net income of $4.2 billion, compared to net income of $1.4 billion for the full year 2023. Net income of $5.94 per share, up 228 percent from the prior year. Adjusted earnings of $5.8 billion, compared to adjusted earnings of $5.5 billion for the full year 2023. Adjusted earnings of $8.15 per share, up 12 percent from the prior year. Adjusted earnings, excluding total notable items, of $5.8 billion, compared to $5.6 billion for the full year 2023. On a per share basis, adjusted earnings, excluding total notable items, of $8.11, up 11 percent from $7.33 for the full ye
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a fourth quarter and full year 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205025824/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institu
144 - METLIFE INC (0001099219) (Subject)
144 - METLIFE INC (0001099219) (Subject)
144 - METLIFE INC (0001099219) (Subject)
8-K - METLIFE INC (0001099219) (Filer)
FWP - METLIFE INC (0001099219) (Subject)
8-K - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
13F-HR - METLIFE INC (0001099219) (Filer)
3 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
MetLife, Inc. (NYSE:MET) today announced that it has confirmed its previously announced declaration of the first quarter 2025 dividend of $0.35516415 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will set an ex-dividend date for the Series A preferred stock. The dividend will be payable March 17, 2025, to shareholders of record as of Feb. 28, 2025, due to the record date occurring on Sunday, March 2, 2025. About MetLife MetLife,
Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh
MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2024 results. Full Year Results Summary Net income of $4.2 billion, compared to net income of $1.4 billion for the full year 2023. Net income of $5.94 per share, up 228 percent from the prior year. Adjusted earnings of $5.8 billion, compared to adjusted earnings of $5.5 billion for the full year 2023. Adjusted earnings of $8.15 per share, up 12 percent from the prior year. Adjusted earnings, excluding total notable items, of $5.8 billion, compared to $5.6 billion for the full year 2023. On a per share basis, adjusted earnings, excluding total notable items, of $8.11, up 11 percent from $7.33 for the full ye
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a fourth quarter and full year 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205025824/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institu
MetLife, Inc. (NYSE:MET) today announced that it will hold a combined fourth quarter and full year 2024 earnings and outlook conference call and audio webcast on Thursday, February 6, 2025, from 9-10 a.m. (ET). The call will follow MetLife's issuance of its fourth quarter and full year 2024 earnings news release, Fourth Quarter 2024 Financial Supplement and outlook materials on Wednesday, February 5, 2025, after the market closes. The news release, Fourth Quarter 2024 Financial Supplement, and outlook materials will also be available on the MetLife Investor Relations webpage (https://investor.metlife.com). The call and accompanying materials will include statements relating to the busines
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a first quarter 2025 common stock dividend of $0.545 per share. The dividend will be payable on March 11, 2025, to shareholders of record as of Feb. 4, 2025. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe an
New five-year strategy to accelerate growth across global platform while delivering attractive returns and all-weather performance Outlines strong long-term financial commitments including double-digit adjusted earnings per share growth1 and 15-17% adjusted return on equity2 MetLife, Inc. (NYSE:MET), one of the world's leading financial services companies, will host its previously announced Investor Day in New York City today. At the Investor Day, MetLife senior executives and other senior leaders will introduce the company's powerful five-year growth strategy, New Frontier, that is designed to support consistent delivery of: Double-digit adjusted earnings per share growth; 15
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.39232690 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cu
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a third quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030606174/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help indivi
MetLife, Inc. (NYSE:MET) today announced its third quarter 2024 results. Third Quarter Results Summary Net income of $1.3 billion, or $1.81 per share, compared to net income of $422 million, or $0.56 per share, in the third quarter of 2023. Adjusted earnings of $1.4 billion, or $1.95 per share, compared to adjusted earnings of $1.5 billion, or $1.97 per share, in the third quarter of 2023. Book value of $39.02 per share, up 33 percent from $29.34 per share at September 30, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $54.72 per share, up 3 percent from $53.00 per share at September 30, 2023.
Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such
MetLife's John Wilson takes over for Kramden founder, who headed the board for two decades As a part of MetLife's, Inc. (NYSE:MET) global strategy to increase diversity in Science, Technology, Engineering and Math (STEM), the company today announced that John Wilson was named chair of the Board of Kramden Institute, a North Carolina non-profit that provides technology and training to bridge the digital divide. Wilson takes over the chair position from the organization's founder, Mark Dibner, who has overseen Kramden's growth for the last 20 years. "We are blessed to have a board of directors passionate about technology and social impact," said Cyndy Yu-Robinson, Kramden Executive Direct
Sofía Belmar to take new role with Latin America regional team and be succeeded by Mario Valdes, who currently oversees six operations in Central and Eastern Europe These changes reinforce MetLife's commitment to cross-region talent development and succession planning After six years of successfully leading MetLife's operation in Mexico – the company's third-largest global operation – Sofía Belmar-Berumen will be taking a new regional role as Head of Business Development and Transformation, Latin America. Belmar's leadership and business acumen have been critical for MetLife Mexico to become the leading player in the local insurance industry. A prominent thought leader, she is the first
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (“MetLife”), announced today that James Reid has been named CEO of Versant Health, a managed vision care company and wholly owned subsidiary of MetLife. The appointment is effective April 1. “James brings extensive and varied experience in the Group Benefits market to Versant Health,” said Todd Katz, chairman of the Versant Health Board of Directors and executive vice president, Group Benefits at MetLife. “His dedication to delivering for customers, focus on building talent and background in both sales and general management makes him ideally suited to lead Versant to new levels of growth.” Reid brings more than 30 years of experience in
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a first quarter 2021 common stock dividend of $0.46 per share. The dividend will be payable on March 15, 2021, to shareholders of record as of Feb. 5, 2021. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United